Leucine is transported into E coli by two osmotic shock-sensitive, high-affinity systems (LIV-I and leucine-specific systems) and one membrane bound, lowaffinity system (LIV -II). Expression of the high-affinity transport systems is altered by mutations in livR and lstR, genes for negatively acting regulatory elements, and by mutations in rho, the gene for transcription termination. All four genes for high-affinity leucine transport (livJ, livK, livH, and livG) are closely linked and have been cloned on a plasmid vector, pOXl. Several subcloned fragments of this plasmid have been prepared and used in complementation and regulation studies. The results of these studies suggest that livJ and livK are separated by approximately one kilobase and give a gene order of livJlivK -livR. livJ and livK appear to be regulated in an interdependent fashion; livK is expressed maximally when the livJ gene is inactivated by mutation or deletion. The results support the existence of separate promoters for the livJ and livK genes. The effects of mutations in the rho and livR genes are additive on one another and therefore appear to be involved in independent regulatory mechanisms. Mutations in the rho gene affect both the LIV-I and leucinespecific transport systems by increasing the expression of livJ and livK, genes for the LIV-specific and leucine-specific binding proteins, respectively.
for both the high-affinity leucine transport systems [8] . All four genes are clustered at minute 74 on the revised E coli linkage map [9] . The LIV-II system is weakly repressed (2-fold) by high exogenous L-leucine levels, in contrast to the more pronounced repression (> lO-fold) observed for the high-affinity leucine transport systems [10] .
Two mutations resulting in reduced regulation of high-affinity leucine transport have been characterized and map at min 20 on the E coli chromosome [11] . These mutations, livR and lstR, appear to code for negatively acting regulatory elements. Mutations in several other gene loci alter the activity of the high-affinity transport systems. These mutations include rho [12] ; hisT, which codes for a tRNA modifying enzyme [13] ; leuS, a gene locus coding for leucyl-tRNA synthetase [14] ; and relA, the gene coding for guanosine 5'-diphosphate 3' -diphosphate (ppGpp) synthesis [15] . These results suggest that normal leucine transport regulation involves interaction of charged or uncharged leucyl-tRNA and rho with transcription and/or translation initiation. The regulation of leucine transport appears similar to that found for the regulation of the biosynthetic operons for tryptophan, histidine, phenylalanine, and leucine [16] [17] [18] [19] .
Recently we have cloned the entire genetic complex coding for the four known LIV-I transport genes into the plasmid vector pACYC184 [20] . When introduced into a wild-type regulatory background, the genes on this hybrid plasmid, pOXl, are subject to regulation. In this paper we present the results of regulation studies with the cloned leucine transport genes and additional characterization of the effect of rho on this regulation.
METHODS

Growth Conditions
Unless otherwise indicated, all strains were grown in MOPS minimal medium [21] with 0.2% glucose, 50 J1g/ml thymine, L-arginine, and L-histidine, 10 J1g/ml of L-tryptophan, and 1 J1g/ml of L-tryptophan, and 1 J1g/ml pyridoxine.
Transport and Binding Protein Assays
Leucine transport was assayed as described previously [11] . Binding proteins were assayed by osmotic treatment of cells [6] and subjecting the concentrated shock fluids to equilibrium dialysis as described previously [4] .
Restriction Endonuclease Digestion, Preparation, and Ligation of Plasmid DNA Endonuclease digestions were performed as described by Boyer et al [22] . All enzymes were purchased from Bethesda Research Labs, Inc. (Bethesda, MD). Plasmid DNA was prepared by,the cleared lysate procedure of Clewell and Helinski [23] and purified by CsCl gradient ultracentrifugation. Plasmid restriction fragments were isolated by electrophoresis on 0.8% agarose gels as described previously [24] . Plasmid pOXl was constructed as described [20] . Plasmids pOX5 [29] and pOX6 were prepared by restricting pOXl with Bgl II and Pst I, respectively, isolating and religating the fragment containing the pACYC 184 vector sequence with T4 DNA ligase. Plasmid pOX7 was prepared by isolating the 2.1 kb Bgl II fragment from pOXl and cloning it into the Bam HI site of pBR322 as described [29] . Plasmid pOX13 was similarly prepared by cloning the 4.4 kb Hind III-Bam HI fragment of pOXl into pBR322 that had been restricted with Bam HI and Hind III. Cultures (2 ml) of pOXl-transformed strain AE89 (livR+ 1 stR+ livH) were grown in MOPS minimal medium plus 0.01 mCi of [3 H ] -L-alanine. Shock fluids were prepared in 0.2 ml of 0.5 mM MgCl 2 as described [6] . Aliquots of shock fluid were electrophoresed in 11% native polyacrylamide gels as described by Laemmli [26] . The binding protein bands were excised from the gel, oxidized in a Packard Sample Oxidizer, and the tritium recovered in scintillation fluid for counting_ TCA precipitates were treated similarily, and the levels of binding proteins were calculated as the percent of total TCA precipitable counts in the binding protein bands.
Detection of Binding Proteins by Nitrocellulose Blot and Antibody Reaction
Native gels of shock fluids were prepared as above. The electrophoresed proteins were transferred to nitrocellulose paper as described by Towbin et al [27] in a Savant electrophoretic destainer. The paper was incubated with [125 I] -labeled anti-LIV-binding protein antibody at 37°C for 4 h in the presence of 3% BSA and 1 % calf serum to prevent nonspecific adsorption. After excess antibody was washed off with PBS, the nitrocellulose paper was dried and autoradiographed.
Transposon tn5 Insertions
Transposon tnS was transferred to the pOXI plasmid by infecting a pOXI plasmidcontaining strain with a temperature sensitive lambda phage carrying the tnS transposon. Infected cells were plated on Luria broth plates containing kanamycin (20 pgjml) and tetracycline-.(l0 pgjml) and incubated at 37°C. Resistant colonies were scraped off the plates and used for plasmid DNA preparation. This plasmid preparation was used to transform strain AE20S (livH livJ). Cells carrying a plasmid with a tnS insertion were selected on kanamycin tetracycline Luria broth plates. Those colonies also resistant to 40 pgjml L-valine (phenotype of LIV-I transport mutant) were selected on minimal media plates and then screened for synthesis of LIV-binding protein and high-affinity LIV-I transport. Colonies that produced LIV-binding protein but were defective in high-affinity L-Ieucine transport contained plasmids with tnS insertions in livH Colonies that did not produce LIV-binding protein and showed high-affinity uptake of L-Ieucine but not L-valine contained plasmids with tnS insertions in livJ.
RESULTS
We have previously reported cloning a 13 kb Eco RI fragment into the plasmid vector pACYC184 to form the pOX 1 plasmid, which was shown to complement all 4 known classes of high-affinity leucine transport mutations [20] . The leucine-specific binding protein gene has been located, and the direction of transcription was determined to be from left to right in Figure 1 . [29] .
Structure of the LlV Transport Region
To define the arrangement of genes in the LIV-I transport region of the pOXI plasmid, we prepared several plasmids containing a subset of the pOXI DNA sequence. Figure 1 shows the portions of the 13 kb Eco RI fragment contained by each of the subcloned plasmids. The deleted plasmids pOXS and pOX6 contain the entire pACYCl84 vector sequence; pOX7 and pOX13 were"prepared by cloning the respective restriction fragments shown in Figure 1 into the plasmid vector pBR322 [25] . The ability of these plasmids to complement previously characterized high-affinity leucine transport mutants was determined by transforming the various mutants with each plasmid and measuring leucine transport. Where appropriate an increase in the synthesis of the binding proteins was detected directly by polyacrylamide gel electrophoresis of shock fluids from transformed strains. The results of these complementation tests, together with the previously published pOXI results [20] , are presented in Table I . We have previously shown by DNA sequencing that livK, the gene for the leucine-specific binding protein,begins 500 bases to the right of the left Bgi II site shown in Figure 1 and is transcribed in the rightward direction [29] . Since pOX13 and not pOX7 complements a mutation in livJ, the gene for the LIV-binding protein, we conclude that livJ is upstream from the livK gene. We have confirmed this result by isolating a plasmid derived from pOXI with a transposon tnS inserted in the livJ gene. This plasmid, pOX1: :tnSlivf24, contains a tnS insertion approximately 500 bases downstream from the right-hand Pst I site, as shown in Figure 2 . A livJ mutant transformed with pOX1: :tnSlivJ24 produced no protein cross-reactive with antibody to the LIV-binding protein. Therefore this tnS insertion must occur early in the livJ gene. RivJ is over 1 kb in length (the molecular weight of the LIV-binding protein is 37,500) and is intact on the pOX6 plasmid, which is deleted between the Pst I sites. Therefore, livJ must also be transcribed from left to right, as shown in Figure 1 . the livJ gene leaves a minimum of one kilobase from its end to the beginning of the livK gene, a distance sufficient to code for an additional protein of up to 35,000 daltons. This region is represented by X in Figure 1 . A comparison of Table I with the plasmid fragments in Figure 1 also reveals that livH must lie at least in part to the left of the right Bgl II site. A tnS transposon insertion in the livH gene of pOXl was isolated which confirms this result. As shown in Figure 2 , pOX 1 : :tnSlivH8 contains a tnS insertion approximately 100 bases downstream from the left Bgl II site. We conc1udelhat this region, represented by Y in Figure 1 , is most likely the livH gene.
Recently we have obtained preliminary DNA sequence information which confirms the gene map shown in Figure 1 . The livJ gene has been located as predicted above. Upstream from livK is a SOO-base AT-rich region that contains numerous nonsense codons in all three reading frames and is likely to be a spacer or regulatory region for the livK gene. Around the right Bgl II site we have located a sequence that contains a single reading frame not interrupted by nonsense codons. When translated, this sequence codes for a basic cysteinerich protein. We expect the livH protein to be both basic and cysteine-rich by analogy to the hisP protein described by Ames and co-workers for high-affinity histidine transport in S typhimurium [30, 31] . A similar basic cysteine-rich coding region has been found in region X. These DNA sequences will be published elsewhere when completed.
Regulation of Plasmid Transport Genes
We have previously shown that the amplified leucine transport present in pOXl transformed strains is regulated by the concentration of L-leucine in the medium [20] . To determine if DNA sequences involved in the regulation of both leucine-binding protein genes are.present in pOXl and its derivatives, we have assayed the level of the LIV-and leucine-specific binding proteins' produced when transformed strains were grown in the presence and absence of leucine. The results of these experiments are shown in Table II. MTN:347 
Synthesis of Leucine-Specific Binding Protein
The interdependent regulation of livJ and livK expression in the plasmids led us to examine the level of leucine-specific binding protein production in non-transformed strains that were defective in livJ, the LIV-binding protein gene. As shown in Table III , the uptakes of L-isoleucine and L-valine, substrates for LIV-binding protein-mediated transport, are not detectable in strain AE840102, which lacks the LIV-binding protein. LLeucine transport, however, is virtually unaffected. That this is due to an increase in leucine-specific binding protein synthesis resulting in an increase in leucine-specific transport is evident from measurements of the level of the binding proteins by equilibrium dialysis of crude shock fluids. While the amount of LIV-binding protein is 20-fold less in strain AE840102 than that in strain AE84, the leucine-specific binding protein is amplified 2-fold.
Mutation of livK in strain AE84084 results in a slight increase in LIV-binding protein activity, which is.also consistent with compensatory regulation of the two binding protein genes. The low levels of L-isoleucine and L-valine uptake in strain AE84084 are probably due to a polar effect of a Mu insertion in livK on the expression of the downstream livH gene.
Rho-Dependent Regulation Is Independent of livR Regulation
It is now well established that mutations in the gene for transcription termination, rho, cause derepression of high-affinity leucine transport [12] . This phenotype is similar to that produced by the livR mutation. We wondered, therefore, whether the two effects were part 1)f the same regulatory mechanism or, alternatively, if the rho effect could still be observed in livR strains already derepressed for leucine transport. To answer this question, we prepared strain AE141 (livR ilv::tnl0) by transduction of the livR strain AE84 with PI phage carrying a transposon tnlO insertion in ilv. Since the rho gene is 85% linked to the ilv locus, we were able to introduce a rho20] mutation into strain AE141 by transducing it with a PI phage grown on a rho20] ilv+ strain (kindly provided by J. Beckwith) and then selecting for ilv+ colonies. As shown in Table IV , leucine uptake was increased MTN:349 over 400% when rho was present in this strain background. On the basis of this result, it is unlikely that rho exerts its effect on leucine transport by altering expression of the livR gene.Thus we conclude that rho-dependent termination is involved in leucine transport regulation in a manner independent of livR repression.
Rho Affects the Expression of Both IivJ and IivK
We previously suggested that the rho-dependent effect on high-affinity leucine transport results from a rho-dependent termination in transcription attenuation of LIV-I transport gene expres~ion [12] .1t is also possible that derepression of LIV-J genes occurs because..a termination upstream from one or more of the genes is relieved by mutations in rho. In the latter .case, one might expect livK expression to be more sensitive to rho mutations than the expression of livJ, since livK is clearly the downstream gene. To assess this possibility, we assayed binding protein synthesis by preparing crude shock fluids of strain X8605 and X8605rho201. The strain X8605 background has previously shown a reduced rho effect in contrast to the effect found in our own strains (Table IV) . We therefore expected strain X8605 shock fluids to show corresponding reduced binding protein levels. These shock fluids were electrophoresed on polyacrylamide gels and transferred to nitrocellulose paper as described in Methods. Table V shows the results of these assays. a LIV-and leucine-specific binding protein synthesis was detected by the antibody nitrocellulose blot method described in Methods. Synthesis was quantitated by determining the amount of [ 125 Il-antibody bound by each band from densitometer tracings of the autoradiographs. It is expressed as the percent relative to LIV-binding protein synthesized by strain X8605 grown without L-leucine after correcting for total protein loaded on the gel. bCells were grown in MOPS minimal medium as described in Methods with or without 0.1 mM L-leucine (13 .ug/ml) and harvested in mid-log phase. cND, not detectable.
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Shock fluid from the rho mutant, strain X8605rho201, contains an elevated concentration of LIV-binding protein relative to shock fluid from the wild-type strain X860S. The leucine-specific binding protein was not detected in shock fluid from strain X860S but was clearly present in shock fluid from strain X8605rho201. Synthesis of neither binding protein was sensitive to regulation by external L-leucine when the rho20llesion was present. These results clearly demonstrate that the expression of both binding protein genes is sensitive to a defective rho termination factor.
DISCUSSION
Previous work in several laboratories has led to the general observation that the level of high-affinity transport can be correlated with the concentration of specific periplasmic binding proteins for a given transport system [10] . The regulation of synthesis of the LIVand leucine-specific binding proteins is a prime determinant, therefore, in controlling the level of high-affinity leucine transport in E coli.
In this paper wellave shown that livJ and livK, genes for the LIV-and leucinespecific binding proteins, respectively, are separated by approximately 1 kb and are capable of independent expression and regulation. Both genes are transcribed in the same direction. It has been shown that transcription and translation of the upstream livJ gene have a definite inhibitory effect on expression of the downstream livK gene. The magnitude of this inhibition is variable. In the X8605 strain background, no detectable leucine-specific binding protein is produced unless a rho lesion is introduced. This result may explain reports by other workers who have not observed leucine-specific uptake in certain E coli strains [32] . The significant levels ofleucine-specific binding protein observed in our laboratory may be due to a high basal level of expression of the livK gene in our E coli strains.
As shown by the data in Tables II and III , the expression of livK may be further stimulated when the livJ gene is mutated or deleted. This result is observed whether livK is in the chromosome or carried on a plasmid. Several explanations for this phenomenon are possible, but the data presented in this paper suggest that the 500 base pair non-coding region directly in front of the livK gene may contain an independent promoter that ordinarily is inactive but that can be activated in response to mutations or other events that reduce livJ expression. Several lines of evidence suggest that this explanation is likely. First, it is clear from the results in Table V that the rho effect cannot be explained solely on the basis of increased read-through of the downstream livK since livJ is also affected. Thus it appears that rho can operate in regulatory regions preceding both the livJ and livK genes. Second, the expression of livK is either unaffected or slightly elevated on the pOXl: :tnSlivJ24 plasmid, which contains the 5.5 kb tnS transposon inserted in the livJ gene. It is unlikely that RNA polymerase, which initiates transcription at a promoter in front of IivJ, would successfully transcribe the entire tnS sequence and continue through to the livK gene. While transcription of the livK gene might initiate at a promoter within the tnS transposon, we consider it more probable that the livK gene has a separate promoter. Third, the expression of the livK gene on the pOX7 plaSmid is still regulated by L-leucine. The effect oLthe regulatory mutations livR and IstR also support this interpretation. Anderson and co-workers have shown that IstR leads to a dramatic derepression of leucine-specific binding protein synthesis, whereas livR leads primarily to an increase in the LIV-binding protein [11] . Both of these lesions map at min 20 on the E coli linkage map. Since these mutations complement each other genetically, they appear to represent MTN:351 536:JSS , Landick et al independent negatively acting regulatory elements. The fact that they differentially affect livJ and livK expression stongly suggests that the livR gene product acts as a promoter in front of livJ, and that the lstR gene product acts as promoter in front of livK. Finally, in support of a separate regulatory region for the livK gene, the 500 base pair AT-rich region, immediately upstream of the livK gene, contains the sequence TGTTTGTCTAT-CAATAAATTCGGAATATTATCTGTTC approximately 250 bases upstream from the livK start codon. This sequence corresponds closely to the conserved elements (underlined) or previously identified RNA polymerase promoters [33] .
In developing a model for leucine transport regulation, the effects of leucyl-tRNA, rho factor, and ppGpp must be considered. With the exception of rho factor, we do not know whether the other regulatory elements alter the expression of only one, or both binding protein genes. In addition, the derepressing effects of mutations hisT and leuSl may be due either to negative regulation by leucyl-tRNA or to a positive effect of uncharged tRNAleu.
Our present understanding of the regulation of high-affinity leucine transport is presented in Figure 3 . This is represented schematically as a working model, and is not intended to represent precisely the interactions of the various regulatory factors. We suggest that two regulatory loci are involved. The first, in front of the livJ gene, ordinarily allows high-efficiency transcription of livJ. Regulation at the livJ promoter is accomplished by the livR gene product, a negative effector for livJ gene expression. In addition, transcription termination factor rho and tRNAleu also regulate livJ expression [10] . As shown in Figure 3 , we suggest that a second regulatory site, most likely including a second promoter, exists directly in front of livK. The product of lstR apparently acts at the livK promoter in a manner similar to the action of livR gene product at the livJ promoter. JSS:537 ities in size and position, suggesting that this duplication involved a larger region than the binding protein gene itself. If the regulatory regions in front of livK and livJ were included in this duplication, then these regions have diverged from a common ancestor, since the two genes are now regulated differently. Additional sequence analysis will provide more information on the evolutionary relationships of the regulatory regions and mechanisms.
